Unlike previous studies, which have primarily focused on insulin therapy for managing hyperglycemia in hospitalized patients, our study highlights the efficacy and safety of oral hypoglycemic agents as an alternative treatment strategy. The gene discussed is INS; the disease is Hyperglycemia.